AR057152A1 - Sistema terapeutico transdermico - Google Patents

Sistema terapeutico transdermico

Info

Publication number
AR057152A1
AR057152A1 ARP060104447A ARP060104447A AR057152A1 AR 057152 A1 AR057152 A1 AR 057152A1 AR P060104447 A ARP060104447 A AR P060104447A AR P060104447 A ARP060104447 A AR P060104447A AR 057152 A1 AR057152 A1 AR 057152A1
Authority
AR
Argentina
Prior art keywords
active ingredient
adhesive solution
transdermal therapeutic
adhesive layer
silicone
Prior art date
Application number
ARP060104447A
Other languages
English (en)
Original Assignee
Novartis Ag
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37716856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR057152(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag, Lohmann Therapie Syst Lts filed Critical Novartis Ag
Publication of AR057152A1 publication Critical patent/AR057152A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Sistemas Terapéuticos Transdérmicos que poseen una capa adhesiva de silicona, a Sistemas Terapéuticos Transdérmicos que proveen concentraciones en plasma específicas, a su elaboracion y uso. Reivindicacion 1: Un Sistema Terapéutico Transdérmico (STT) que comprende a) una capa posterior, b) una capa reservorio que comprende uno o más ingredientes farmacéuticamente activos y uno o más polímeros, c) una capa adhesiva que comprende un taquificante y un polímero de silicona. Reivindicacion 8: El STT de acuerdo con cualquiera de las reivindicaciones 1 a 6, caracterizado en que el ingrediente activo está seleccionado del grupo integrado por agonistas de alfa-adrenoreceptor, agonistas de beta-adrenoreceptor, bloqueantes de alfa- adrenoreceptor, analgésicos anestésicos, analgésicos no anestésicos, androgenos, anestésicos, antialérgicos, antiandrogenos, antianginales, antiarrítmicos, penicilinas, antidiabéticos, antihistamínicos, agentes antimigrana, alcaloides ergot hidratados, antagonistas de Ca++, antagonistas de serotonina, inhibidores de agregacion plaquetaria, antidepresivos, bronquiolíticos, estrogenos, gestágenos, vasodilatadores, hormonas, fármacos anti-demencia. Reivindicacion 9: El STT de acuerdo con cualquiera de las reivindicaciones 1 a 6, caracterizado en que el ingrediente activo está seleccionado el grupo integrado por tacrina, rivastigmina, donepezil, galantamina, fisostigmina, huperzina A y las sales farmacologicamente aceptables de las mismas. Reivindicacion 20: Un proceso para elaborar un STT de acuerdo con cualquiera de las reivindicaciones precedentes que comprende las etapas de a) la elaboracion del ingrediente activo en solucion adhesiva; b) el recubrimiento del ingrediente activo en solucion adhesiva; c) el secado del ingrediente activo en solucion adhesiva, d) la elaboracion de la solucion adhesiva de silicona; e) el recubrimiento de la solucion adhesiva de silicona, f) el laminado de la capa adhesiva de silicona al fármaco en la capa adhesiva, g) la perforacion y el embolsado.
ARP060104447A 2005-12-01 2006-10-10 Sistema terapeutico transdermico AR057152A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74151105P 2005-12-01 2005-12-01

Publications (1)

Publication Number Publication Date
AR057152A1 true AR057152A1 (es) 2007-11-21

Family

ID=37716856

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP060104447A AR057152A1 (es) 2005-12-01 2006-10-10 Sistema terapeutico transdermico
ARP140102752A AR097045A2 (es) 2005-12-01 2014-07-24 Sistema terapéutico transdérmico

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP140102752A AR097045A2 (es) 2005-12-01 2014-07-24 Sistema terapéutico transdérmico

Country Status (31)

Country Link
US (3) US20070128263A1 (es)
EP (5) EP2292219B9 (es)
JP (3) JP2009517468A (es)
KR (7) KR20210008440A (es)
CN (2) CN102048713A (es)
AR (2) AR057152A1 (es)
AT (1) AT11185U1 (es)
AU (1) AU2006320919B2 (es)
BR (2) BR122013013162A2 (es)
CA (1) CA2563110A1 (es)
DE (2) DE202006021172U1 (es)
DK (5) DK2292219T3 (es)
EC (1) ECSP088469A (es)
ES (1) ES2414455T3 (es)
FI (1) FI10268U1 (es)
GT (1) GT200800075A (es)
IL (4) IL191311A (es)
MA (1) MA30022B1 (es)
MY (2) MY151020A (es)
NO (1) NO20082753L (es)
NZ (1) NZ568273A (es)
PH (2) PH12013500771A1 (es)
PL (1) PL2292219T4 (es)
PT (1) PT2292219E (es)
RU (1) RU2450805C2 (es)
SG (1) SG2014014989A (es)
SI (1) SI2292219T1 (es)
TN (1) TNSN08238A1 (es)
TW (1) TWI389709B (es)
WO (1) WO2007064407A1 (es)
ZA (1) ZA200803882B (es)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
US9248104B2 (en) * 2006-08-17 2016-02-02 Core Tech Solutions, Inc. Transdermal methods and systems for treating Alzheimer's disease
TWI541246B (zh) 2008-12-08 2016-07-11 歐陸斯迪公司 二氫羥戊甲嗎啡
GB0823554D0 (en) 2008-12-24 2009-01-28 Novartis Ag Process for the preparation of optically active compounds using transfer hydrogenation
BRPI1006655A2 (pt) * 2009-04-17 2016-02-10 3M Innovative Properties Co construção de adesivo de gel de silicone e métodos para a produção de uma construção de adesivo de gel de silicone
WO2010129689A1 (en) * 2009-05-05 2010-11-11 Forest Laboratories Holdings Limited Milnacipran formulations
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
TR201902233T4 (tr) 2009-10-30 2019-03-21 Ix Biopharma Ltd Hızlı çözünen katı dozaj formu.
WO2011073362A1 (en) 2009-12-18 2011-06-23 Novartis Ag Process for the preparation of optically active compounds using pressure hydrogenation
EP2515886B1 (de) 2009-12-22 2018-04-11 Luye Pharma AG Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
US20100178307A1 (en) * 2010-01-13 2010-07-15 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
RU2578971C2 (ru) * 2010-06-17 2016-03-27 Лтс Ломанн Терапи-Системе Аг Трансдермальное введение мемантина
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
BR112013001550A2 (pt) * 2010-07-21 2016-05-24 3M Innovative Properties Co composições, dispositivos e métodos de adesivos trandérmicos
CA2807552A1 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
US20120046383A1 (en) * 2010-08-19 2012-02-23 Terumo Kabushiki Kaisha Silicone rubber composition
ES3005233T3 (en) 2010-10-01 2025-03-14 Modernatx Inc Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
RS54173B1 (sr) * 2010-12-14 2015-12-31 Acino Ag Transdermalni terapijski sistem za davanje aktivne supstance
KR101788802B1 (ko) * 2010-12-24 2017-10-20 주식회사 삼양바이오팜 리바스티그민을 함유하는 경피흡수제제
KR101054317B1 (ko) * 2011-01-28 2011-08-08 신신제약 주식회사 리바스티그민을 함유하는 경피흡수제제
KR101317158B1 (ko) 2011-02-18 2013-10-15 조선대학교산학협력단 갈란타민 또는 그의 염을 함유하는 경피흡수제제
JP2014511687A (ja) 2011-03-31 2014-05-19 モデルナ セラピューティクス インコーポレイテッド 工学操作された核酸の送達および製剤
WO2012161489A2 (ko) * 2011-05-20 2012-11-29 에스케이케미칼 주식회사 리바스티그민 함유 패취
KR20120130073A (ko) * 2011-05-20 2012-11-28 에스케이케미칼주식회사 리바스티그민 함유 패취
CN103796645B (zh) 2011-08-31 2017-06-20 东洋油墨Sc控股株式会社 贴剂
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
EP2763701B1 (en) 2011-10-03 2018-12-19 Moderna Therapeutics, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
JP2015501844A (ja) 2011-12-16 2015-01-19 モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 修飾ヌクレオシド、ヌクレオチドおよび核酸組成物
KR101399035B1 (ko) * 2011-12-22 2014-05-28 주식회사 트랜스덤 리바스티그민을 함유하는 경피흡수제제
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
SG11201404815YA (en) 2012-02-28 2014-10-30 Nichiban Kk Transdermal patch
WO2013142339A1 (en) 2012-03-23 2013-09-26 Novartis Ag Transdermal therapeutic system and method
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
WO2013151663A1 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of membrane proteins
US9254311B2 (en) 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US20150051559A1 (en) * 2012-04-05 2015-02-19 Sparsha Pharma International Private Limited Transdermal patch for treatment of dementia or alzheimer type dementia
JP6153135B2 (ja) * 2012-06-12 2017-06-28 株式会社 ケイ・エム トランスダーム 貼付剤
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
CN104582693A (zh) * 2012-08-15 2015-04-29 道康宁公司 多层药物递送系统
EP2893927A4 (en) * 2012-09-03 2016-03-09 Nipro Patch Co Ltd SKIN PATCH
KR20140038237A (ko) * 2012-09-20 2014-03-28 에스케이케미칼주식회사 리바스티그민의 안정성이 개선된 의약품
US20140083878A1 (en) * 2012-09-21 2014-03-27 Mylan Inc. Transdermal drug delivery device
US9895320B2 (en) 2012-09-28 2018-02-20 KM Transderm Ltd. Transdermal patch with different viscosity hydrocarbon oils in the drug layer and the adhesive layer
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
ES2921623T3 (es) 2012-11-26 2022-08-30 Modernatx Inc ARN modificado terminalmente
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
WO2014111790A2 (en) 2013-01-15 2014-07-24 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
RU2560668C2 (ru) * 2013-03-04 2015-08-20 Общество с ограниченной ответственностью Научно-производственное объединение "Клеточные технологии" Трансдермальный седативный фармацевтический гель для лечения психоэмоциальных расстройств
US20140271866A1 (en) * 2013-03-15 2014-09-18 Nal Pharmaceuticals, Ltd. Transdermal drug delivery system containing rivastigmine
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
AR095259A1 (es) * 2013-03-15 2015-09-30 Noven Pharma Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method
TWI745577B (zh) * 2013-06-12 2021-11-11 日商Ｋｍ特蘭斯達股份有限公司 經皮吸收製劑
JP6427733B2 (ja) 2013-06-12 2018-11-28 株式会社 ケイ・エム トランスダーム 皮膚貼付用粘着シートおよびそれを用いた経皮吸収製剤
CA2916183C (en) 2013-07-03 2022-03-29 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system with electronic component
KR20160067219A (ko) 2013-10-03 2016-06-13 모더나 세라퓨틱스, 인코포레이티드 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
RU2648449C2 (ru) 2013-10-07 2018-03-26 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы и композиции для трансдермальной доставки неседативного количества дексмедетомидина
RU2018105761A (ru) 2013-10-07 2019-02-26 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Устройства для трансдермальной доставки дексмедетомидина и способы их применения
TWI709417B (zh) 2013-10-07 2020-11-11 美商帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
CN105813636A (zh) 2013-12-12 2016-07-27 久光制药株式会社 带覆盖材料的贴附剂及带覆盖材料的贴附剂套件
CN103877063A (zh) * 2014-03-24 2014-06-25 张绪伟 一种重酒石酸卡巴拉汀胶囊及其制备方法
WO2015156990A1 (en) 2014-04-08 2015-10-15 Teikoku Pharma Usa, Inc. Rivastigmine transdermal compositions and methods of using the same
JPWO2015174502A1 (ja) 2014-05-15 2017-05-25 ニチバン株式会社 リバスチグミンを含有する貼付剤のための包装体
JP6573913B2 (ja) 2014-05-20 2019-09-11 エルテーエス ローマン テラピー−ジステーメ アーゲー ロチゴチンを含む経皮送達システム
JP6895755B2 (ja) 2014-05-20 2021-06-30 エルテーエス ローマン テラピー−ジステーメ アーゲー 経皮送達システムにおける活性薬剤の放出を調節するための方法
EP4238580A3 (en) 2014-05-20 2023-10-25 LTS Lohmann Therapie-Systeme AG Transdermal delivery system including an interface mediator
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
CN204119542U (zh) 2014-09-24 2015-01-21 上海荣威塑胶工业有限公司 一种ptc加热器
CN104523656A (zh) * 2014-11-20 2015-04-22 美吉斯制药（厦门）有限公司 一种卡巴拉汀缓释透皮贴剂及其制备方法
WO2016088898A1 (ja) 2014-12-05 2016-06-09 株式会社 ケイ・エム トランスダーム 皮膚貼付用粘着シートおよびそれを用いた経皮吸収製剤
DE102015107743A1 (de) 2015-05-18 2016-11-24 Bsn Medical Gmbh Silikongelbeschichtete adhäsive Schichtstruktur
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9980921B2 (en) * 2016-06-30 2018-05-29 Taho Pharmaceuticals Ltd. Transdermal delivery system containing methylphenidate or its salts and methods thereof
CN109640976B (zh) 2016-08-22 2023-10-17 救急药品工业株式会社 贴附剂
KR20210113439A (ko) 2016-10-31 2021-09-15 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치를 이용한 통증을 관리하는 방법
PL3338768T3 (pl) 2016-12-20 2020-05-18 Lts Lohmann Therapie-Systeme Ag Transdermalny system terapeutyczny zawierający asenapinę
ES3001152T3 (es) 2016-12-20 2025-03-04 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transdérmico que contiene asenapina y polisiloxano o poliisobutileno
KR102033686B1 (ko) * 2017-05-19 2019-10-18 보령제약 주식회사 도네페질을 함유하는 마이크로니들 경피 패치
JP2020532582A (ja) 2017-09-05 2020-11-12 エルテーエス ローマン テラピー−ジステーメ アーゲー リバスチグミンの経皮投与のための経皮治療システム
CA3092757A1 (en) * 2018-03-13 2019-09-19 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system comprising a silicone acrylic hybrid polymer
BR112020018290A2 (pt) * 2018-03-13 2020-12-29 Lts Lohmann Therapie-Systeme Ag Sistema terapêutico transdérmico compreendendo um polímero híbrido de silicone e acrílico
BR112020018607A2 (pt) * 2018-03-13 2020-12-29 Lts Lohmann Therapie-Systeme Ag Sistema terapêutico transdérmico compreendendo um polímero híbrido de silicone acrílico
CA3101418A1 (en) * 2018-06-19 2019-12-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing rivastigmine
EP3810099A1 (en) 2018-06-20 2021-04-28 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system containing asenapine
AU2019291060B2 (en) 2018-06-20 2024-09-05 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
US12151030B2 (en) 2019-01-31 2024-11-26 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
WO2021005118A1 (en) * 2019-07-09 2021-01-14 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system comprising an active agent-containing layer comprising an acrylic polymer and a skin contact layer comprising a silicone gel adhesive
BR112021024461A2 (pt) * 2019-07-09 2022-01-18 Lts Lohmann Therapie Systeme Ag Sistema terapêutico transdérmico compreendendo uma camada contendo agente ativo compreendendo um polímero contendo silicone e uma camada de contato com a pele compreendendo um adesivo de gel de silicone
CN113616625B (zh) * 2021-08-26 2023-05-30 大连科翔科技开发有限公司 一种卡巴拉汀的长效透皮贴剂
WO2024160939A1 (en) * 2023-02-01 2024-08-08 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for the transdermal administration of huperzine a

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL195004C (nl) 1987-03-04 2003-11-04 Novartis Ag Fenylcarbamaat bevattend farmaceutisch preparaat.
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5252335A (en) * 1989-07-12 1993-10-12 Cygnus Therapeutic Systems Transdermal administration of lisuride
DE4301783C1 (de) * 1993-01-23 1994-02-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil
US6316023B1 (en) 1998-01-12 2001-11-13 Novartis Ag TTS containing an antioxidant
GB9800526D0 (en) * 1998-01-12 1998-03-11 Ciba Geigy Ag Organic compounds
DE19918106A1 (de) * 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
DE19922662C1 (de) * 1999-05-18 2000-12-28 Sanol Arznei Schwarz Gmbh Transdermales therapeutisches System (TTS) Tolterodin enthaltend
EP1231877A4 (en) * 1999-11-04 2009-03-18 Xel Herbaceuticals TRANSDERMALE ADMINISTRATION OF HUPERZIN
US20020192243A1 (en) * 1999-12-16 2002-12-19 Tsung-Min Hsu Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
TWI287455B (en) * 2000-12-05 2007-10-01 Noven Pharma Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use
DE10103860B4 (de) 2001-01-30 2004-12-23 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
WO2003020289A1 (en) * 2001-08-30 2003-03-13 Ortho-Mcneil Pharmaceutical, Inc. Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors
DE10159745A1 (de) * 2001-12-05 2003-07-03 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort
EP1509232B1 (en) * 2002-05-31 2008-11-19 H. Lundbeck A/S A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
AU2003274353B2 (en) * 2002-10-24 2007-04-05 Merz Pharma Gmbh & Co. Kgaa Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
EP1718291A1 (en) 2004-02-19 2006-11-08 Novartis AG Use of cholinesterase inhibitors for treating vascular depression
TWI389709B (zh) 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
EP2596889B1 (en) * 2011-11-23 2017-04-26 Sandvik Intellectual Property AB A cutting insert and a milling tool

Also Published As

Publication number Publication date
NZ568273A (en) 2011-06-30
CA2563110A1 (en) 2007-06-01
BRPI0619758A2 (pt) 2011-10-18
TW200732001A (en) 2007-09-01
IL191311A (en) 2015-02-26
WO2007064407A1 (en) 2007-06-07
IL234291A (en) 2017-02-28
KR20080071581A (ko) 2008-08-04
EP2292219B1 (en) 2013-06-12
EP2292219B9 (en) 2015-02-18
EP1959937A1 (en) 2008-08-27
DK201300059U1 (da) 2013-04-29
GT200800075A (es) 2010-06-01
PL2292219T4 (pl) 2014-03-31
EP2292219A1 (en) 2011-03-09
JP2013177419A (ja) 2013-09-09
DE202006021172U1 (de) 2013-05-07
RU2008126459A (ru) 2010-01-20
AU2006320919B2 (en) 2011-04-28
MY151020A (en) 2014-03-31
HK1153646A1 (en) 2012-04-05
JP6298034B2 (ja) 2018-03-20
KR20130143729A (ko) 2013-12-31
AU2006320919A1 (en) 2007-06-07
JP5938612B2 (ja) 2016-06-22
SG2014014989A (en) 2014-06-27
DK2292219T3 (da) 2013-06-24
PH12013500772B1 (en) 2018-04-20
AT11185U1 (de) 2010-06-15
US20130266633A1 (en) 2013-10-10
CN101312717A (zh) 2008-11-26
MY162986A (en) 2017-07-31
DK201300014U1 (da) 2013-02-08
TWI389709B (zh) 2013-03-21
PH12013500772A1 (en) 2016-01-18
RU2450805C2 (ru) 2012-05-20
FI10268U1 (fi) 2013-10-18
KR20170033449A (ko) 2017-03-24
PH12013500771A1 (en) 2016-01-18
DE14163637T1 (de) 2015-06-03
US20140134230A1 (en) 2014-05-15
TNSN08238A1 (en) 2009-10-30
DK201600113U1 (da) 2017-01-13
AR097045A2 (es) 2016-02-17
PT2292219E (pt) 2013-06-24
EP3235495A1 (en) 2017-10-25
KR20210008440A (ko) 2021-01-21
DK201300059U3 (da) 2013-05-13
SI2292219T1 (sl) 2013-08-30
ZA200803882B (en) 2009-03-25
DK201300015U1 (en) 2013-02-08
EP2786748A1 (en) 2014-10-08
ES2414455T3 (es) 2013-07-19
PL2292219T3 (pl) 2013-09-30
US20070128263A1 (en) 2007-06-07
IL250734A0 (en) 2017-04-30
NO20082753L (no) 2008-08-19
KR20140072108A (ko) 2014-06-12
JP2016104737A (ja) 2016-06-09
DK201300014U3 (da) 2013-05-13
MA30022B1 (fr) 2008-12-01
IL234364A (en) 2016-06-30
KR20180050441A (ko) 2018-05-14
BR122013013162A2 (pt) 2015-06-30
KR20220156666A (ko) 2022-11-25
JP2009517468A (ja) 2009-04-30
DK201300015Y4 (da) 2016-02-12
ECSP088469A (es) 2008-07-30
DK201600113Y4 (da) 2017-06-09
CN102048713A (zh) 2011-05-11
EP2286802A1 (en) 2011-02-23

Similar Documents

Publication Publication Date Title
RU2008126459A (ru) Трансдермальная терапевтическая система
KR102536696B1 (ko) 향상된 투과성을 가지는 약물학적 조성물
JP5049268B2 (ja) マイクロニードルデバイスおよびマイクロニードル付き経皮薬物投与装置
AR072492A1 (es) Dispositivo y administracion transdermica de estrogeno
EP2589379A4 (en) TRANSDERMAL AGGREGATE FREEZING SYSTEM WITH DONEPEZIL
MX2022006681A (es) Sistema de suministro transdermico de donepezilo.
AR039336A1 (es) Sistemas analgesicos transdermicos con potencial de abuso reducido
JP2024012484A (ja) 増強された透過を有する医薬組成物
CY1109861T1 (el) Διαδερμικο θεραπευτικο συστημα για την ασθενεια του παρκινσον που προκαλει υψηλα επιπεδα πλασματος της ροτιγοτινης
AR037081A1 (es) Composicion para el suministro transdermico de fentanilo
AR039744A1 (es) Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
JP7003211B2 (ja) 日に１回の取り替えによるフェンタニルの経皮投与
AR048862A1 (es) Aparatos y metodos para el suministro transdermico de una vacuna antigripal
AR005281A1 (es) Composicion farceutica oral , procedimientos para su manufactura y uso de esa composicion farmaceutica para la preparacion de medicamentos. .
AR064078A1 (es) Sistema de administracion de farmacos intraocular inyectable biocompatible, su uso para preparar un medicamento y proceso para su preparacion
JP6369992B2 (ja) 溶解型マイクロニードル製剤
NO20031875D0 (no) Transdermale legemiddelleveringsanordninger med belagte mikrofremspring
AR065579A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
PA8815901A1 (es) Sistema de administracion de drogas con efecto estabilizante
TWI659754B (zh) Micro needle sheet
DK2613784T3 (da) Indretning til transdermal indgivelse af lægemiddel
BRPI0411032A (pt) composição adesiva hidrófila, artigo médico, método para a fabricação da composição adesiva, e, dispositivo de administração transdérmica
CN102065900B (zh) 经皮吸收促进剂和使用其的经皮给药制剂
BRPI0514252A (pt) sistema de elastoplasto de microprotusões sem agulha
JP2005535686A5 (es)

Legal Events

Date Code Title Description
FC Refusal